Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression
  2. Lucchesi, Christopher A.; Zhang, Jin; Ma, Buyong; Chen, Mingyi; Chen, Xinbin
  3. CANCER RESEARCH. 2019, FEB 15; 79(4): 807-818.
  1. 2.   Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Cross, A. J.
  3. International Journal of Cancer. 2012, Apr; 130(7): 1649-1659.
  1. 3.   Intervening in beta-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis
  2. Stein, U.; Arlt, F.; Smith, J.; Sack, U.; Herrmann, P.; Walther, W.; Lemm, M.; Fichtner, I.; Shoemaker, R. H.; Schlag, P. M.
  3. Neoplasia. 2011, Feb; 13(2): 131-144.
  1. 4.   Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Colburn, N. H.; Cross, A. J.
  3. British Journal of Cancer. 2010, Oct; 103(9): 1453-1461.
  1. 5.   Cancer and Inflammation: Promise for Biologic Therapy
  2. Demaria, S.; Pikarsky, E.; Karin, M.; Coussens, L. M.; Chen, Y. C.; El-Omar, E. M.; Trinchieri, G.; Dubinett, S. M.; Mao, J. T.; Szabo, E.; Krieg, A.; Weiner, G. J.; Fox, B. A.; Coukos, G.; Wang, E.; Abraham, R. T.; Carbone, M.; Lotze, M. T.
  3. Journal of Immunotherapy. 2010, May; 33(4): 335-351.
  1. 6.   Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia
  2. Berndt, S. I.; Huang, W. Y.; Yeager, M.; Weissfeld, J. L.; Chanock, S. J.; Hayes, R. B.
  3. Cancer Causes & Control. 2009 20(4): 487-490.
  1. 7.   The Untapped Potential of Genetically Engineered Mouse Models in Chemoprevention Research: Opportunities and Challenges
  2. Abate-Shen, C.; Brown, P. H.; Colburn, N. H.; Gerner, E. W.; Green, J. E.; Lipkin, M.; Nelson, W. G.; Threadgill, D.
  3. Cancer Prevention Research. 2008 1(3): 161-166.
  1. 8.   Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk
  2. Berndt, S. I.; Potter, J. D.; Hazra, A.; Yeager, M.; Thomas, G.; Makar, K. W.; Welch, R.; Cross, A. J.; Huang, W. Y.; Schoen, R. E.; Giovannucci, E.; Chan, A. T.; Chanock, S. J.; Peters, U.; Hunter, D. J.; Hayes, R. B.
  3. Human Molecular Genetics. 2008 17(17): 2665-2672.
  1. 9.   Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours
  2. Ivanova, A. V.; Vortmeyer, A.; Ivanov, S. V.; Nickerson, M. L.; Maher, E. R.; Lerman, M. I.
  3. Journal of Pathology. 2008 214(1): 46-57.
  1. 10.   Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas
  2. Chen, M.; Rahman, L.; Voeller, D.; Kastanos, E.; Yang, S. X.; Feigenbaum, L.; Allegra, C.; Kaye, F. J.; Steeg, P.; Zajac-Kaye, M.
  3. Oncogene. 2007, Jul; 26(33): 4817-4824.
  1. 11.   Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells
  2. Lou, J. R.; Fatima, N.; Xiao, Z.; Stauffer, S.; Smythers, G.; Greenwald, P.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2006, Sep; 15(9): 1598-1606.
  1. 12.   Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma
  2. Moslehi, R.; Chatterjee, N.; Church, T. R.; Chen, J.; Yeager, M.; Weissfeld, J.; Hein, D. W.; Hayes, R. B.
  3. Pharmacogenomics. 2006, Sep; 7(6): 819-829.
  1. 13.   Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro
  2. Ciolino, H. P.; MacDonald, C. J.; Memon, O. S.; Bass, S. E.; Yeh, G. C.
  3. Carcinogenesis. 2006, Aug; 27(8): 1586-1592.
  1. 14.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 15.   Precancer in mice: Animal models used to understand, prevent, and treat human precancers
  2. Cardiff, R. D.; Anver, M. R.; Boivin, G. P.; Bosenberg, M. W.; Maronpot, R. R.; Molinolo, A. A.; Nikitin, A. Y.; Rehg, J. E.; Thomas, G. V.; Russell, R. G.; Ward, J. M.
  3. Toxicologic Pathology. 2006 34(6): 699-707.
  1. 16.   Transforming growth factor beta 1 (TGF beta 1) polymorphisms and advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Welch, R.; Chanock, S. J.; Pinsky, P.; Weissfeld, J. L.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2756S-2756S.
  1. 17.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 18.   CYP1A1 Val(462) and NQO1 Ser(187) polymorphisms, cigarette use, and risk for colorectal adenoma
  2. Hou, L. F.; Chatterjee, N.; Huang, W. Y.; Baccarelli, A.; Yadavalli, S.; Yeager, M.; Bresalier, R. S.; Chanock, S. J.; Caporaso, N. E.; Ji, B. T.; Weissfeld, J. L.; Hayes, R. B.
  3. Carcinogenesis. 2005, JUN; 26(6): 1122-1128.
  1. 19.   Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma
  2. Huang, W. Y.; Chatterjee, N.; Chanock, S.; Dean, M.; Yeager, M.; Schoen, R. E.; Hou, L. F.; Berndt, S. I.; Yadavalli, S.; Johnson, C. C.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, JAN; 14(1): 152-157.
  1. 20.   Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: Role of inclusion body formation
  2. Waalkes, M. P.; Liu, J.; Goyer, R. A.; Diwan, B. A.
  3. Cancer Research. 2004, NOV 1; 64(21): 7766-7772.
  1. 21.   Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk
  2. Peters, U.; Hayes, R. B.; Chatterjee, N.; Shao, W.; Schoen, R. E.; Pinsky, P.; Hollis, B. W.; McGlynn, K. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004 13(4): 546-552.
  1. 22.   Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
  2. Zhen, X. A.; Luke, B. T.; Izmirlian, G.; Umar, A.; Lynch, P. M.; Phillips, R. K. S.; Patterson, S.; Conrads, T. P.; Veenstra, T. D.; Greenwald, P.; Hawk, E. T.; Ali, L. U.
  3. Cancer Research. 2004 64(8): 2904-2909.
  1. 23.   Exercise and intestinal polyp development in APC(Min) mice
  2. Colbert, L. H.; Mai, V.; Perkins, S. N.; Berrigan, D.; Lavigne, J. A.; Wimbrow, H. H.; Alvord, W. G.; Haines, D. C.; Srinivas, P.; Hursting, S. D.
  3. Medicine and Science in Sports and Exercise. 2003 35(10): 1662-1669.
  1. 24.   Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation
  2. Liu, S. L.; Lerman, M. I.; Miller, A. D.
  3. Journal of Virology. 2003 77(14): 7924-7935.
  1. 25.   Increased serum corticosterone and glucose in offspring of chromium(III)-treated male mice
  2. Cheng, R. Y. S.; Alvord, W. G.; Powell, D.; Kasprzak, K. S.; Anderson, L. M.
  3. Environmental Health Perspectives. 2002 110(8): 801-804.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel